Clinical Trial Update: Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tirabrutinib as maintenance therapy versus placebo in patients with primary central nervous system lymphoma in complete remi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Tirabrutinib (tirabrutinib)

Snippet

Sponsor: Kyorin University | Conditions: Primary Central Nervous System Lymphoma | Phase 2 | Status: RECRUITING